Group One Trading’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-83,500
| Closed | -$785K | – | 7305 |
|
|
2020
Q3 | $785K | Buy |
83,500
+9,900
| +13% | +$94.1K | ﹤0.01% | 2418 |
|
|
2020
Q2 | $563K | Buy |
73,600
+11,700
| +19% | +$89.5K | ﹤0.01% | 2537 |
|
|
2020
Q1 | $383K | Buy |
61,900
+34,500
| +126% | +$304K | ﹤0.01% | 2240 |
|
|
2019
Q4 | $333K | Buy |
27,400
+6,600
| +32% | +$72.1K | ﹤0.01% | 2780 |
|
|
2019
Q3 | $240K | Sell |
20,800
-683,200
| -97% | -$7.19M | ﹤0.01% | 2950 |
|
|
2019
Q2 | $7.03M | Buy |
704,000
+701,100
| +24,176% | +$7.56M | 0.06% | 368 |
|
|
2019
Q1 | $37K | Sell |
2,900
-1,100
| -28% | -$16.4K | ﹤0.01% | 3728 |
|
|
2018
Q4 | $61K | Sell |
4,000
-4,000
| -50% | -$76.2K | ﹤0.01% | 3452 |
|
|
2018
Q3 | $5K | Sell |
8,000
-9,300
| -54% | -$212K | ﹤0.01% | 4870 |
|
|
2018
Q2 | $337K | Buy |
17,300
+2,800
| +19% | +$61.9K | ﹤0.01% | 2629 |
|
|
2018
Q1 | $292K | Hold |
14,500
| – | – | ﹤0.01% | 2493 |
|
|
2017
Q4 | $192K | Sell |
14,500
-4,000
| -22% | -$60.3K | ﹤0.01% | 2951 |
|
|
2017
Q3 | $341K | Buy |
18,500
+3,400
| +23% | +$63.4K | ﹤0.01% | 2368 |
|
|
2017
Q2 | $278K | Buy |
15,100
+14,900
| +7,450% | +$295K | ﹤0.01% | 2408 |
|
|
2017
Q1 | $5K | Buy |
+200
| New | +$4.79K | ﹤0.01% | 4304 |
|
|
2016
Q3 | – | Sell |
-700
| Closed | -$17K | – | 5082 |
|
|
2016
Q2 | $17K | Buy |
+700
| New | +$16K | ﹤0.01% | 3877 |
|
|
2016
Q1 | – | Sell |
-1,900
| Closed | -$57K | – | 5157 |
|
|
2015
Q4 | $57K | Sell |
1,900
-1,300
| -41% | -$42K | ﹤0.01% | 3334 |
|
|
2015
Q3 | $127K | Sell |
3,200
-16,500
| -84% | -$1.02M | ﹤0.01% | 2873 |
|
|
2015
Q2 | $1.36M | Buy |
19,700
+15,200
| +338% | +$956K | 0.02% | 987 |
|
|
2015
Q1 | $246K | Sell |
4,500
-1,200
| -21% | -$57.2K | ﹤0.01% | 2218 |
|
|
2014
Q4 | $243K | Buy |
5,700
+4,500
| +375% | +$163K | ﹤0.01% | 2143 |
|
|
2014
Q3 | $38K | Buy |
1,200
+200
| +20% | +$4.26K | ﹤0.01% | 3729 |
|
|
2014
Q2 | $21K | Buy |
+1,000
| New | +$18.5K | ﹤0.01% | 4134 |
|
Group One Trading's AMAG Position: Q1 2019 in Review
Group One Trading sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 16,288 shares — an estimated $243K sold.
Group One Trading first reported a position in AMAG in Q1 2014 and held it in 14 quarters. The position peaked at $894K in Q1 2017. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.
- Group One Trading reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
- Group One Trading sold 16,288 AMAG Pharmaceuticals shares in Q1 2019, an estimated $243K.
- Group One Trading first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 14 quarters.
- Group One Trading's AMAG Pharmaceuticals position peaked at $894K in Q1 2017.
- 166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.
Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.